1. Kamar N., Bendall R., Legrand-Abravanel F., Xia N.S., Ijaz S., Izopet J. et al. Hepatitis E. Lancet. 2012; 379: 2477-88.
2. Favorov M.O., Shakhgil’dian I.V., Iashina T.L., Onishchenko G.G., Firsova S.N., Eraliev A.E. The characteristics of an outbreak of non-A, non-B hepatitis with a fecal-oral mechanism of the transmission of the causative agent in Osh Province, the Kirghiz SSR. Zhurnal mikrobiologii, epidemiologii I immunobiologii. 1990; 11: 37-44. (in Russian)
3. WHO/IVB/10.14 The Global Prevalence of Hepatitis E Virus Infection and Susceptibility: A Systematic Review. December 2010: 23-4.
4. Javed N., Ullah S.H., Hussain N., Sheikh M.A., Khan A., Ghafoor F. et al. Hepatitis E virus seroprevalence in pregnant women in Pakistan: maternal and fetal outcomes. East Mediterr. Health J. 2017; 23(8): 559-63.
5. Murali A.R., Kotwal V., Chawla S. Chronic hepatitis E: A brief review. World J. Hepatol. 2015; 7(19): 2194-201.